BBR Partners’s Allergan plc AGN Stock Holding History

BBR Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,570	Closed	-$264K	–	105
2018 Q1	$264K	Buy	+1,570	New	+$263K	0.05%	77

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBR Partners's AGN Position: Q2 2018 in Review

BBR Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 1,570 shares — an estimated $264K sold.

BBR Partners first reported a position in AGN in Q1 2018 and held it in 1 quarter. The position peaked at $264K in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

BBR Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
BBR Partners sold 1,570 Allergan plc shares in Q2 2018, an estimated $264K.
BBR Partners first reported a position in Allergan plc in Q1 2018 and held it in 1 quarter.
BBR Partners's Allergan plc position peaked at $264K in Q1 2018.
1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on BBR Partners's 13F filing for Q2 2018, filed 14 Aug 2018.